Cargando…
Reversal of the Apoptotic Resistance of Non-Small-Cell Lung Carcinoma towards TRAIL by Natural Product Toosendanin
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) selectively triggers cancer cell death via its association with death receptors on the cell membrane, but exerts negligible side effects on normal cells. However, some non-small-cell lung carcinoma (NSCLC) patients exhibited resistance...
Autores principales: | Li, Xin, You, Ming, Liu, Yong-jian, Ma, Lin, Jin, Pei-pei, Zhou, Ri, Zhang, Zhao-Xin, Hua, Baojin, Ji, Xiao-jun, Cheng, Xiao-ying, Yin, Fangzhou, Chen, Yan, Yin, Wu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314365/ https://www.ncbi.nlm.nih.gov/pubmed/28209994 http://dx.doi.org/10.1038/srep42748 |
Ejemplares similares
-
Toosendanin inhibits adipogenesis by activating Wnt/β-catenin signaling
por: Chen, Tian-xing, et al.
Publicado: (2018) -
The Apoptotic Effects of Toosendanin Are Partially Mediated by Activation of Deoxycytidine Kinase in HL-60 Cells
por: Ju, Jianming, et al.
Publicado: (2012) -
Toosendanin induces the apoptosis of human Ewing's sarcoma cells via the mitochondrial apoptotic pathway
por: Gao, Tian, et al.
Publicado: (2019) -
Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3
por: Zhang, T, et al.
Publicado: (2017) -
Correction: Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3
por: Zhang, T., et al.
Publicado: (2019)